NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?
- 1Department of Pathology, Free University Medical Center, PO Box 7057, 1007 MB Amsterdam, 1006 AD Amsterdam, The Netherlands
- 2Central Laboratory of the Netherlands Blood Transfusion Service (CLB) and Laboratory for Experimental and Clinical Immunology, Academic Medical Center, University of Amsterdam, The Netherlands
- 3Department of Cardiac Surgery, Free University Medical Center,
- 4Institute of Cardiovascular Research, Free University Medical Center
- Correspondence to: Dr H W M Niessen, Department of Pathology, Free University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands; jwm.niessen{at}vumc.nl
- Accepted 6 March 2002
Abstract
Reactive oxygen species play an important role in a variety of (patho)physiological vascular processes. Recent publications have produced evidence of a role for putative non-phagocyte NADP oxidase(s) in the vascular production of reactive oxygen species. In the present review, we discuss the detection of the different components of NADP oxidase(s) in the vascular system, together with the putative role of reactive oxygen species produced by vascular NADPH oxidase(s), in both in vitro and in vivo studies.
- Ang, angiotensin
- CAD, coronary artery disease
- CGD, chronic granulomatous disease
- DPI, diphenylene iodonium
- ER, endoplasmic reticulum
- HUVEC, human umbilical vein endothelial cell
- LPS, lipopolysaccharide
- PMA, phorbol-12-myristate-13-acetate
- ROS, reactive oxygen species
- RT-PCR, reverse transcriptase polymerase chain reaction
- SMC, smooth muscle cell
- TNF-α, tumour necrosis factor α
- VSMC, vascular smooth muscle cell
Footnotes
-
The first two authors contributed equally to the preparation of this paper.
